Univariate | Multivariate | |||
---|---|---|---|---|
HR (95%CI) | p | HR (95%CI) | p | |
Age | 1.063(1.036–1.09) | < 0.001 | 1.060(1.033–1.088) | < 0.001 |
Endometroid (+/-) | 0.479(0.246–0.932) | 0.03 | 0.792(0.302–2.077) | 0.635 |
Comprehensive surgery staging (+/-) | 0.661(0.418–1.046) | 0.077 | ||
Maximum diameter of tumor | 1.098(0.967–1.245) | 0.148 | ||
High-intermediate and high risk (+/-) | 1.877(1.201–2.934) | 0.006 | 1.314(0.672–2.573) | 0.425 |
Poor differentiate and undifferentiated (+/-) | 2.315(1.441–3.719) | < 0.001 | 1.852(0.907–3.708) | 0.090 |
Myometrial infiltration ≧ 1/2(+/-) | 1.290(0.824–2.021) | 0.265 | ||
LVSI (+/-) | 1.249(0.711–2.196) | 0.439 | ||
LUSI (+/-) | 1.276(0.798–2.041) | 0.309 | ||
Cervix invasion (+/-) | 1.142(0.636–2.048) | 0.657 | ||
Radiotherapy modality (EBRT + VBT or EBRT/VBT) | 1.108(0.708–1.733) | 0.655 | ||
Chemotherapy (+/-) | 0.688(0.410–1.157) | 0.158 |